Publications Archive - 2017

Recent Posts

Medical Law International: The challenge of human challenge research models: A Canadian perspective

Research in which healthy volunteers are exposed to pathogens or other aetiologic agents that may cause disease remains controversial. Proponents suggest such work is key to understanding pathways of infection and the efficacy of vaccines and treatments. Yet, this research creates ethical and legal issues surrounding consent, participant vulnerability and the potential for harm. Moreover, public trust in research could be compromised if avoidable, serious harm occurs, making challenge research risky. Among Canadian research ethics guidelines, overarching messages are that participant interests cannot be subservient to those of research and that risks must be proportional to likely benefits. Moreover, common law fiduciary obligations to clinical research participants and the deterrent effect of potential tortious or criminal negligence act to reinforce the idea that challenge protocols should be a strategy of last resort. Researchers could benefit from clear guidance directly addressing the unique issues with challenge research.

Sage Journals: Pragmatic clinical trials and the consent process

Publication by Blake Murdoch and Timothy Caulfield.

National Library of Medicine: Marketing of unproven stem cell-based interventions: A call to action

Looking at the proliferation of unproven stem cells marketed direct to consumers we identified some "Co-opted tokens of scientific legitimacy”

Journal of Law and Biosciences: Injecting doubt: responding to the naturopathic anti-vaccination rhetoric

Little evidence to support much of what naturopaths offer. And the sensible advice (exercise, sleep) often wrapped in a blanket of pseudoscience.

CNTRP: Understanding Opt-Out or Presumed Consent - what are the challenges and how would it work in Canada?

This Fast Fact briefly explains the framework and implications of opt-out consent for deceased organ donation, describes the social and legal challenges with adopting an opt-out consent model in Canada and raises important questions to consider. Produced by Maeghan Toews with the input from the CNTRP team and with support from Canadian Blood Services.

Regenerative Medicine: Human gene editing: revisiting Canadian policy

Combatting Unlicensed Stem Cell Interventions through Truthful Advertising Law: A Survey of Regulatory Trends

Professor Ogbogu proposes the adoption and application of consumer protection legal frameworks, specifically truthful advertising laws and enforcement strategies, as a means of combating the proliferation of clinics offering and providing unproven and unlicensed stem cell interventions to the public.